Newsroom

Published 11/20/2020

Media Fact Sheet: AAOS Fracture & Trauma Registry Adds Amgen as Sponsor

ROSEMONT, Ill. (November 20, 2020)—The American Academy of Orthopaedic Surgeons (AAOS) announces Amgen as the first industry sponsorship for the AAOS’ Fracture & Trauma Registry (FTR), which begins with a limited invitation to key sites in late 2020 with full participant enrollment in spring 2021. Support from Amgen allows the FTR to further invest in the technology and science that is needed to evolve the Registry and better meet the needs of all major stakeholders, including physicians, patients, payors, regulatory groups, and industry partners.

WHY NOW? FRACTURE RISK WITH ADVANCING AGE
Trauma contributes to a large portion of orthopaedic conditions and procedures. Skeletal fragility, in combination with a greater propensity to fall, results in an increased susceptibility to fractures with aging. Osteoporosis-related fractures, known as bone breaks, are common. Each year an estimated 1.5 million people suffer an osteoporosis-related facture.[1]. Osteoporosis-related fractures are projected to increase nationally to over 3 million fractures in 2025[2].

With sponsors like Amgen, the FTR is poised to begin collecting data on five of the more common fractures in the United States, including hip fracture (a collaborative module with the AAOS American Joint Replacement Registry), distal radius fracture, ankle fracture, distal femur fracture, and proximal humerus fracture (future module planned in collaboration with the AAOS Shoulder & Elbow Registry).

“To roll out the Fracture & Trauma Registry with the support of Amgen is exciting. The collaboration helps create an even stronger foundation for collecting robust quality data that can drive improved patient outcomes. Together we are setting the stage for standardized reporting for quality orthopaedic care.”
Michael J. Gardner, MD, FAAOS
Chair, AAOS Fracture & Trauma Registry Steering Committee

 

“Breaking a bone due to osteoporosis can be a life-altering event that can lead to pain, loss of mobility and a change in lifestyle.3,4 Amgen’s support of the AAOS Fracture & Trauma Registry, which is dedicated to tracking evidence-based best practices supporting the highest quality of care, further underscores our commitment to moving from the current break and fix healthcare model to a model that can better predict and help prevent fractures before they happen.”
—César Cerezo, MD, PhD
Vice President Global Medical, Amgen

ABOUT THE FRACTURE & TRAUMA REGISTRY
The FTR is the fifth in a series of anatomical, evidence-based registries that are part of the AAOS’ Registry Program, each designed to utilize data for making critical clinical and resource-related decisions to improve quality of care for patients. It is the first AAOS Registry built on a synergistic approach where collaborative modules will be available across the RegistryInsights® platform, offering expanded, crossover benefits to AAOS Registry Program participants.

All orthopaedic surgeons who may encounter fractures in their practice are encouraged to participate in the FTR. To get involved with the FTR, email an AAOS Registry engagement associate at RegistryEngagement@aaos.org call 847-292-0530, or visit www.aaos.org/registries.

###

Follow the AAOS on FacebookTwitterLinkedIn and Instagram.

[1] U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004.
[2] Burge R, Dawson-Hughes B, Solomon DH, et al.: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–475.
3 Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis [published correction appears in Osteoporos Int. 2015 Jul;26(7):2045-7]. Osteoporos Int. 2014;25(10):2359‐2381.
4 Inacio MC, Weiss JM, Miric A, Hunt JJ, Zohman GL, Paxton EW. A Community-Based Hip Fracture Registry: Population, Methods, and Outcomes. Perm J. 2015;19(3):29‐36.

Contact AAOS Media Relations 

Deanna Killackey 
847-384-4035
killackey@aaos.org

 

Lauren Riley 
847-384-4031
pearson@aaos.org